Tech Company Financing Transactions
MagForce USA Funding Round
MagForce USA, operating out of Berlin, secured $15 million from Mithril Capital Management and private investors.
Transaction Overview
Company Name
Announced On
8/12/2014
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Mithril Capital Management (Lead Investor) (Ajay Royan)
Proceeds Purpose
MagForce USA's growth round with proceeds of USD 15 million, with an option to increase the size of the round to USD 30 million. MagForce AG owns 77% of MagForce USA as of this closing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Max-Planck-Strasse 3
Berlin, 12489
Germany
Berlin, 12489
Germany
Phone
Website
Email Address
Overview
MagForce AG, listed in the entry standard of the Frankfurt Stock Exchange (MF6, ISIN: DE000A0HGQF5), together with its subsidiary MagForce USA, Inc. is a leading medical device company in the field of nanomedicine focused on oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ben Lipps
Chief Financial Officer
Christian Volkmann
Chief Medical Officer
Hoda Tawfik
Browse more venture capital transactions:
Prev: 8/12/2014: 360fly venture capital transaction
Next: 8/12/2014: Scilex Pharmaceuticals venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs